• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病细菌机制及潜在肠上皮细胞治疗靶点的新见解

New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease.

作者信息

Liang Bing, Wu Changhao, Wang Chao, Sun Wenshe, Chen Wujun, Hu Xiaokun, Liu Ning, Xing Dongming

机构信息

Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Biochemistry and Physiology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.

出版信息

Front Microbiol. 2022 Dec 16;13:1065608. doi: 10.3389/fmicb.2022.1065608. eCollection 2022.

DOI:10.3389/fmicb.2022.1065608
PMID:36590401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9802581/
Abstract

The global incidence of inflammatory bowel disease (IBD) has increased rapidly in recent years, but its exact etiology remains unclear. In the past decade, IBD has been reported to be associated with dysbiosis of gut microbiota. Although not yet proven to be a cause or consequence of IBD, the common hypothesis is that at least some alterations in the microbiome are protective or pathogenic. Furthermore, intestinal epithelial cells (IECs) serve as a protective physical barrier for gut microbiota, essential for maintaining intestinal homeostasis and actively contributes to the mucosal immune system. Thus, dysregulation within the intestinal epithelium increases intestinal permeability, promotes the entry of bacteria, toxins, and macromolecules, and disrupts intestinal immune homeostasis, all of which are associated with the clinical course of IBD. This article presents a selective overview of recent studies on bacterial mechanisms that may be protective or promotive of IBD in biological models. Moreover, we summarize and discuss the recent discovery of key modulators and signaling pathways in the IECs that could serve as potential IBD therapeutic targets. Understanding the role of the IECs in the pathogenesis of IBD may help improve the understanding of the inflammatory process and the identification of potential therapeutic targets to help ameliorate this increasingly common disease.

摘要

近年来,炎症性肠病(IBD)的全球发病率迅速上升,但其确切病因仍不清楚。在过去十年中,有报道称IBD与肠道微生物群失调有关。尽管尚未被证明是IBD的原因或结果,但常见的假设是,微生物组的至少一些改变具有保护作用或致病性。此外,肠道上皮细胞(IEC)作为肠道微生物群的保护性物理屏障,对于维持肠道稳态至关重要,并积极促进黏膜免疫系统。因此,肠道上皮内的失调会增加肠道通透性,促进细菌、毒素和大分子的进入,并破坏肠道免疫稳态,所有这些都与IBD的临床病程相关。本文选择性地概述了近期在生物学模型中关于可能对IBD具有保护或促进作用的细菌机制的研究。此外,我们总结并讨论了IEC中关键调节因子和信号通路的最新发现,这些可能成为IBD潜在的治疗靶点。了解IEC在IBD发病机制中的作用可能有助于加深对炎症过程的理解,并有助于识别潜在的治疗靶点,以帮助改善这种日益常见的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/46ce9765dac1/fmicb-13-1065608-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/2dcef1d132f4/fmicb-13-1065608-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/d5e8434c4a78/fmicb-13-1065608-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/46ce9765dac1/fmicb-13-1065608-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/2dcef1d132f4/fmicb-13-1065608-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/d5e8434c4a78/fmicb-13-1065608-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c9/9802581/46ce9765dac1/fmicb-13-1065608-g003.jpg

相似文献

1
New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease.炎症性肠病细菌机制及潜在肠上皮细胞治疗靶点的新见解
Front Microbiol. 2022 Dec 16;13:1065608. doi: 10.3389/fmicb.2022.1065608. eCollection 2022.
2
Intestinal epithelium in inflammatory bowel disease.炎症性肠病中的肠上皮。
Front Med (Lausanne). 2014 Aug 25;1:24. doi: 10.3389/fmed.2014.00024. eCollection 2014.
3
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.《交战规则:上皮-微生物相互作用与炎症性肠病》
Front Med (Lausanne). 2021 Aug 27;8:669913. doi: 10.3389/fmed.2021.669913. eCollection 2021.
4
New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.口腔微生物失调在炎症性肠病发病机制中的作用的新见解。
Dig Dis Sci. 2022 Jan;67(1):42-55. doi: 10.1007/s10620-021-06837-2. Epub 2021 Feb 1.
5
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
6
Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.修复屏障:炎症性肠病中的上皮屏障及其与黏膜免疫的关系
Cell Mol Gastroenterol Hepatol. 2017 Mar 23;4(1):33-46. doi: 10.1016/j.jcmgh.2017.03.007. eCollection 2017 Jul.
7
Association between intestinal microbiota and inflammatory bowel disease.肠道微生物群与炎症性肠病的关系。
Animal Model Exp Med. 2022 Dec;5(4):311-322. doi: 10.1002/ame2.12255. Epub 2022 Jul 8.
8
Know your neighbors: microbial recognition at the intestinal barrier and its implications for gut homeostasis and inflammatory bowel disease.了解你的邻居:肠道屏障处的微生物识别及其对肠道稳态和炎症性肠病的影响。
Front Cell Dev Biol. 2023 Jul 14;11:1228283. doi: 10.3389/fcell.2023.1228283. eCollection 2023.
9
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.炎症性肠病中的微生物组:从发病机制到治疗。
Protein Cell. 2021 May;12(5):331-345. doi: 10.1007/s13238-020-00745-3. Epub 2020 Jun 29.
10
Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.利用犬肠道类器官生物学加深对炎症性肠病发病机制的理解并加速药物发现:一种“同一健康”方法
Front Toxicol. 2021 Nov 10;3:773953. doi: 10.3389/ftox.2021.773953. eCollection 2021.

引用本文的文献

1
Quantitative Alterations in Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.炎症性肠病中短链脂肪酸的定量变化:系统评价与荟萃分析
Biomolecules. 2025 Jul 15;15(7):1017. doi: 10.3390/biom15071017.
2
Comprehensive computational strategies for multi-target drug discovery in inflammatory bowel disease utilizing bioactive compounds.利用生物活性化合物进行炎症性肠病多靶点药物发现的综合计算策略
Sci Rep. 2025 May 3;15(1):15542. doi: 10.1038/s41598-025-98771-w.
3
Debate on the relationship between infection and inflammatory bowel disease: a bibliometric analysis.

本文引用的文献

1
DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon.DNA 甲基转移酶 3A 控制结肠中肠道上皮屏障功能和再生。
Nat Commun. 2022 Oct 21;13(1):6266. doi: 10.1038/s41467-022-33844-2.
2
NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures.NOX1 对于 TNFα 诱导的肠道上皮细胞 ROS 分泌是必需的,并且抑制 M 细胞特征。
Gut. 2023 Apr;72(4):654-662. doi: 10.1136/gutjnl-2021-326305. Epub 2022 Oct 3.
3
MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT.
感染与炎症性肠病关系的辩论:一项文献计量分析
Front Microbiol. 2024 Nov 6;15:1479941. doi: 10.3389/fmicb.2024.1479941. eCollection 2024.
4
The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer.口腔微生物群失调对口腔癌病因、发病机制及发展的影响
Cancers (Basel). 2024 Aug 28;16(17):2997. doi: 10.3390/cancers16172997.
5
Exploring the therapeutic potential of cinnamoyl derivatives in attenuating inflammation in lipopolysaccharide-induced Caco-2 cells.探讨肉桂酰衍生物在减轻脂多糖诱导的 Caco-2 细胞炎症中的治疗潜力。
Future Med Chem. 2024;16(14):1395-1411. doi: 10.1080/17568919.2024.2351293. Epub 2024 May 29.
6
Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review.药用植物、植物化学物质与炎症性肠病中NLRP3炎性小体的调控:综述
Metabolites. 2023 Jun 6;13(6):728. doi: 10.3390/metabo13060728.
MPST 缺乏通过 AKT 促进肠道上皮细胞凋亡并加重炎症性肠病。
Redox Biol. 2022 Oct;56:102469. doi: 10.1016/j.redox.2022.102469. Epub 2022 Sep 11.
4
The role and regulatory mechanism of mA methylation in the nervous system.mA甲基化在神经系统中的作用及调控机制。
Front Genet. 2022 Sep 1;13:962774. doi: 10.3389/fgene.2022.962774. eCollection 2022.
5
RhoB affects colitis through modulating cell signaling and intestinal microbiome.RhoB 通过调节细胞信号和肠道微生物组来影响结肠炎。
Microbiome. 2022 Sep 16;10(1):149. doi: 10.1186/s40168-022-01347-3.
6
The miR-181 family regulates colonic inflammation through its activity in the intestinal epithelium.miR-181 家族通过其在肠道上皮细胞中的活性来调节结肠炎症。
J Exp Med. 2022 Dec 5;219(12). doi: 10.1084/jem.20212278. Epub 2022 Sep 8.
7
Enterobacter ludwigii protects DSS-induced colitis through choline-mediated immune tolerance.阴沟肠杆菌通过胆碱介导的免疫耐受来保护 DSS 诱导的结肠炎。
Cell Rep. 2022 Aug 30;40(9):111308. doi: 10.1016/j.celrep.2022.111308.
8
Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis.具核梭杆菌细胞外囊泡通过miR-574-5p/CARD3轴调节自噬促进实验性结肠炎
Inflamm Bowel Dis. 2023 Jan 5;29(1):9-26. doi: 10.1093/ibd/izac177.
9
Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression.微生物代谢物在肠道上皮细胞中协调一个独特的多层次调控网络,该网络指导 P-糖蛋白的表达。
mBio. 2022 Aug 30;13(4):e0199322. doi: 10.1128/mbio.01993-22. Epub 2022 Aug 15.
10
TLR4 regulates RORγt regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila.TLR4 通过与阿克曼氏菌的相互作用调节 RORγt 调节性 T 细胞反应和对结肠炎症的易感性。
Microbiome. 2022 Jun 27;10(1):98. doi: 10.1186/s40168-022-01296-x.